-
-
13/03/2024 14/03/2024 America/Toronto Controlled Substances - Regulation, Litigation, and Enforcement Private: Controlled Substances – Regulation, Litigation, and Enforcement
March 13 – 14, 2024
Washington, DC
Please visit https://www.americanconference.com/controlled-substances/ for more information and updates. Washington, DC true DD/MM/YYYY 1440 use-title -
-
-
13/03/2024 14/03/2024 America/Toronto Controlled Substances - Regulation, Litigation, and Enforcement Private: Controlled Substances – Regulation, Litigation, and Enforcement
March 13 – 14, 2024
Washington, DC
Please visit https://www.americanconference.com/controlled-substances/ for more information and updates. Washington, DC true DD/MM/YYYY 1440 use-title -
Pharmacist Spotlight
What Every Pharmacist and Non-Pharmacist Needs to Know About Proper Administration and Diversion of Prescribed Controlled Substances
Janet Hart
Director, Government Affairs
Rite Aid
Elliot M. Schachner
Assistant U.S. Attorney, Eastern District of New York
U.S. Department of Justice
- Lessons learned from recent pharmacy chain rulings regarding diversion and how to not let this happen to your business
- Developing best practices for communicating with prescribers when the necessity of the prescription is in question
- Protocols for following up with prescriber red flags
- Knowing which red flags to report
- Analyzing guidelines and factors for determining the likelihood of diversion from the patient
- Utilizing the Prescription Drug Monitoring Program as a tool
- Going beyond reporting: can pharmacists refuse to fill prescriptions?
- Incorporating the Model State Pharmacy Act and Model Rules of National Association of Boards of Pharmacy (Model Act) and the PhRMA Code